I3A, produced by the indole-3-pyruvic acid pathway and aromatic amino acid aminotransferase via the gut microbiota [35], can activate AHR to enhance tumour malignancy and suppress anti-tumour immunity [36]. The gene discussed is AHR; the disease is neoplasm.